title: [Multidisciplinary team meetings settings on the management of women at high risk of inherited breast cancer. A French study].
abstract: BACKGROUND
  In France, 126 centers for cancer genetics coordinate genetic testing and high-risk cancer surveillance for individuals and their families with hereditary cancer syndromes. Since 2012, the French National Cancer Institute (INCa) supports 17 projects to promote and manage the monitoring of individuals genetically predisposed to cancer. They were assigned 4 missions by INCa including expertise for difficult cases.
  
  
  METHODS
  We initiated a national survey to assess how the oncogenetic clinics responded to the 4th mission for women at high risk of developing breast cancers. We sent the survey to all the French oncogeneticists. We aimed at evaluating the modalities and the extent of implementation of the Multidisciplinary team (MDT) meetings regarding the management of women who have genetically higher risks to develop breast cancer.
  
  
  RESULTS
  Fourteen people from 12 administrative regions, who represent 10 of the 17 projects, answered the form. Eleven participants reported the submission of medical cases in Oncogenetics MDT meetings (79 %), 5 in senology MDT meetings (36 %), 5 in MDT meetings dedicated to patients at high risk for breast cancer (36 %) and 2 in network meetings (14 %). Some structures discuss medical cases through different MDT meetings.
  
  
  CONCLUSIONS
  Although MDT meetings are valuable practices to optimize treatment or management options for patients, its settings might be subject to difficulties to federate the appropriate-number of participants as well as cost-effectiveness issues. This survey thus suggests the need of a standardized process of MDT meetings while taking account specificities of oncogenetics.
authors.affiliation: CHRU de Strasbourg, hôpitaux universitaires de Strasbourg, UF6948 oncogénétique : évaluation familiale et suivi, pôle d'hématologie et oncologie, 1, place de l'Hôpital, BP 426, 67091 Strasbourg cedex, France. Electronic address: fanchon.gillmann@chru-strasbourg.fr.
authors.forename: Fanchon
authors.initials: F
authors.lastname: Gillmann
authors.affiliation: CHRU de Strasbourg, hôpitaux universitaires de Strasbourg, UF6948 oncogénétique : évaluation familiale et suivi, pôle d'hématologie et oncologie, 1, place de l'Hôpital, BP 426, 67091 Strasbourg cedex, France.
authors.forename: Christophe
authors.initials: C
authors.lastname: Cordier
authors.affiliation: CHRU de Strasbourg, hôpitaux universitaires de Strasbourg, UF6948 oncogénétique : évaluation familiale et suivi, pôle d'hématologie et oncologie, 1, place de l'Hôpital, BP 426, 67091 Strasbourg cedex, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Taris
authors.affiliation: CHRU, hôpitaux universitaires de Strasbourg, hôpital de Hautepierre, unité de sénologie, avenue Molière, 67200 Strasbourg cedex, France.
authors.forename: Carole
authors.initials: C
authors.lastname: Mathelin
authors.affiliation: CHRU de Strasbourg, hôpitaux universitaires de Strasbourg, UF6948 oncogénétique : évaluation familiale et suivi, pôle d'hématologie et oncologie, 1, place de l'Hôpital, BP 426, 67091 Strasbourg cedex, France.
authors.forename: Christine M
authors.initials: CM
authors.lastname: Maugard
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics / Q000628:therapy*; D032921:Consensus; D003245:Consensus Statements as Topic; D019468:Disease Management; D005260:Female; D005602:France; D020022:Genetic Predisposition to Disease; D006801:Humans; D008495:Medical Oncology; D011795:Surveys and Questionnaires
keywords: BRCA; Breast cancer; Cancer du sein; Multidisciplinary team (MDT) meetings; Réunion de concertation pluridisciplinaire